Vincent Zoete is developing computer tools to fight cancer. The chemist, who heads two groups at the University of Lausanne and the Swiss Institute of Bioinformatics, predicts the effects of new drugs.
GSK’s new PhIII data support bid for wider endometrial cancer label for Jemperli
GSK’s PD-1 antibody Jemperli has hit the benchmark in a late-stage endometrial cancer test, paving the way for a potential label expansion beyond its current
March 19, 2024